Towards Healthcare
North America Cell and Gene Therapy Market
Updated Date: 13 October 2025   |   Report Code: 6297
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

North America Cell and Gene Therapy Market Advanced Therapies Drives Rapid Growth

According to forecasts, the North America cell and gene therapy market will grow from USD 9.19 billion in 2024 to USD 79.01 billion by 2034, with an expected CAGR of 24.01%. The North America cell and gene therapy market is growing due to the rising demand for highly specific therapeutics for genetic disorders.

Last Updated : 13 October 2025 Category: Therapeutic Area Insight Code: 6297 Format: PDF / PPT / Excel

Content

TOC is not Available for this Report

FAQ's

Answer : The North America cell and gene therapy market in 2025 is valued at USD 11.34 billion and is projected to climb to USD 79.01 billion by 2034, with a CAGR of 24.01% over the forecast period.

Answer : The U.S. is currently leading the North America cell and gene therapy market due to government support and initiatives taken by organizations such as the FDA.

Answer : Some key players include Novartis AG, Bluebird Bio, CRISPR Therapeutics, Bristol Myers Squibb, etc.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar